Vivio® LVEDP System
Adjunctive Heart Failure Status Indicator. 510(k) K223905, from Avicena, LLC (Pasadena, CA). Product code QUO, class 2.
As of Nov 21, 2026, K223905 is an FDA 510(k) held by Avicena, LLC, substantially equivalent on Oct 6, 2023 after 282 days, with no recalls tied to it in FDA's recall database.
- Review time: 282 days
- Recalls: 0
The Vivio® System is indicated to non-invasively estimate left ventricular end-diastolic pressure (LVEDP) is above or below 18mmHg. This measurement can aid in the diagnosis of heart failure when used by qualified healthcare professionals as an adjunct alongside other clinically relevant information. For use in adults only.
- EchoGo Heart FailureK222463 · Ultromics Limited · Nov 23, 2022
- CardioVisionK251293 · Icardio.Ai · Nov 21, 2025
- EchoGo Heart Failure (2.0)K240013 · Ultromics Limited · Sep 23, 2024
- EchoGo Heart FailureK222463 · Ultromics Limited · Nov 23, 2022
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 28, 2022
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2200
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files